4D Molecular Therapeutics Ownership | Who Owns 4D Molecular Therapeutics?
4D Molecular Therapeutics Ownership Summary
4D Molecular Therapeutics is owned by 116.37% institutional investors, 3.48% insiders. Ra capital management is the largest institutional shareholder, holding 10.35% of FDMT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.96% of its assets in 4D Molecular Therapeutics shares.
FDMT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | 4D Molecular Therapeutics | 116.37% | 3.48% | -19.85% |
| Sector | Healthcare Stocks | 47.31% | 8.01% | 44.69% |
| Industry | Biotech Stocks | 45.43% | 7.81% | 46.75% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 5.10M | 10.35% | $107.01M |
| Blackrock | 4.90M | 9.94% | $102.79M |
| Vr adviser | 4.40M | 8.93% | $92.36M |
| Goldman sachs group | 4.13M | 8.39% | $86.78M |
| Deep track capital, lp | 4.06M | 8.24% | $85.25M |
| Bvf inc/il | 3.92M | 7.96% | $82.33M |
| Janus henderson group | 3.20M | 6.49% | $67.11M |
| Vanguard group | 2.53M | 5.13% | $53.07M |
| State street | 2.08M | 4.22% | $43.64M |
| Polar capital | 1.74M | 3.54% | $36.62M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Vr adviser | 4.40M | 5.88% | $92.36M |
| Deep track capital, lp | 4.06M | 2.54% | $85.25M |
| Bvf inc/il | 3.92M | 2.31% | $82.33M |
| Decheng capital | 347.83K | 2.24% | $7.30M |
| Eagle health investments lp | 462.91K | 1.70% | $9.72M |
| Novo | 1.40M | 1.47% | $29.39M |
| Ra capital management | 5.10M | 1.42% | $107.01M |
| Redmile group | 1.07M | 1.36% | $22.53M |
| Casdin capital | 800.00K | 1.28% | $16.79M |
| Sphera funds management | 242.53K | 0.69% | $5.09M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Goldman sachs group | 4.13M | 0.01% | 1.08M |
| Deep track capital, lp | 4.06M | 2.54% | 1.03M |
| Blackrock | 4.90M | 0.00% | 612.35K |
| Panagora asset management | 354.86K | 0.04% | 252.79K |
| Vanguard group | 2.53M | 0.00% | 188.24K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Viking global investors lp | - | - | -2.93M |
| Braidwell lp | 369.46K | 0.24% | -683.03K |
| Lmr partners llp | - | - | -487.53K |
| Opaleye management | - | - | -345.75K |
| Ubs group | 67.14K | 0.00% | -307.05K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Hudson bay capital management lp | 113.30K | 0.01% | 113.30K | $2.38M |
| Gsa capital partners llp | 64.88K | 0.10% | 64.88K | $1.36M |
| Twinbeech capital lp | 58.62K | 0.02% | 58.62K | $1.23M |
| Corebridge financial | 26.81K | 0.00% | 26.81K | $562.70K |
| Mirae asset global etfs | 24.75K | 0.00% | 24.75K | $519.26K |
Sold Out
| Holder | Change |
|---|---|
| Innealta capital | -4.00 |
| Rothschild investment | -5.00 |
| Nelson, van denburg & campbell wealth management group | -8.00 |
| Federated hermes | -27.00 |
| Allworth financial lp | -28.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 146 | -6.41% | 57,338,955 | 1.87% | 116 | 0.89% | 82 | -21.15% | 38 | 2.70% |
| Mar 31, 2024 | 156 | 33.33% | 56,284,675 | 32.64% | 114 | 0.97% | 104 | 62.50% | 37 | 32.14% |
| Dec 31, 2023 | 117 | 1.74% | 42,433,938 | 1.23% | 108 | 1.10% | 64 | 1.59% | 28 | -15.15% |
| Sep 30, 2023 | 115 | 8.49% | 41,916,662 | 1.06% | 99 | 0.85% | 63 | -11.27% | 33 | 73.68% |
| Jun 30, 2023 | 106 | 8.16% | 41,475,360 | 36.41% | 108 | 1.25% | 71 | 39.22% | 19 | -26.92% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.54M | 2.96% | - |
| iShares Russell 2000 ETF | 1.31M | 2.52% | -2.94K |
| Janus Henderson Global Life Sciences D | 1.03M | 1.97% | -710.00 |
| Janus Henderson Global Life Sciences | 1.02M | 1.96% | -10.84K |
| SPDR® S&P Biotech ETF | 996.42K | 1.92% | 11.02K |
| Eventide Healthcare & Life Sciences I | 881.16K | 1.70% | 105.04K |
| Polar Capital Healthcare Opports Inc | 790.16K | 1.52% | - |
| Janus Global Life Science AUSD | 750.90K | 1.44% | 6.30K |
| Janus Henderson Glb Life Scn I2 USD | 750.90K | 1.44% | 3.46K |
| Vanguard Institutional Extnd Mkt Idx Tr | 589.15K | 1.13% | 8.74K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 16, 2024 | Bizily Scott | Chief Legal Officer | Sell | $8.16K |
| Aug 19, 2024 | Bizily Scott | Chief Legal Officer | Sell | $7.50K |
| Jul 16, 2024 | Bizily Scott | Chief Legal Officer | Sell | $47.44K |
| Jul 11, 2024 | Bizily Scott | Chief Legal Officer | Sell | $49.90K |
| Jul 10, 2024 | Kirn David | Chief Executive Officer | Sell | $290.60K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q3 | - | 6 |
| 2024 Q2 | - | 6 |
| 2024 Q1 | - | 13 |
| 2023 Q4 | - | 2 |
| 2023 Q3 | - | - |
FDMT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools